Bariatric surgery patients are at increased risk of nutritional deficiencies that can result in the devastating effects of metabolic bone disease. Endocrinologist Susan Williams, RD, MD, MS, discusses her recommendations for preoperative screening and interventions to normalize nutritional and bone indices prior to surgery.
Sleep interventions may help improve quality of life of patients with both endometrial cancer and obesity, a new Case Comprehensive Cancer Center study finds. Co-authors Jay Alberts, PhD, and Chad Michener, MD, explain.
Helping patients lose weight is difficult in one office visit. In this article, obesity specialist Marcio Greibeler, MD, explains how Cleveland Clinic’s multidisciplinary approach to medical weight loss management creates more touch points with patients for long-term success.
A new Cleveland Clinic-developed risk calculator helps patients with obesity and Type 2 diabetes understand and discuss with their physician the long-term risks of mortality and cardiovascular and renal morbidity, with and without bariatric surgery, allowing for a more informed treatment decision.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Candidates for ablation for symptomatic atrial fibrillation who have severe obesity should be considered for bariatric surgery prior to ablation, a new study suggests.
A large matched-cohort study in patients with type 2 diabetes and obesity finds that metabolic surgery confers significant improvements in all prespecified events plus marked reductions in weight, HbA1c, and use of diabetes and cardiovascular medications.
Americans’ awareness of the links between body weight and heart health is spotty, a national survey shows. But at least one finding underscores an opportunity for heart-healthy change.
Patients will now have a single point of entry for evidence-based weight management.
Multisite phosphorylation alters adipocyte metabolism via a kinase called S6K1. This pathway could be an attractive target for therapeutic development.
Cleveland Clinic endocrinologists see improved clinical outcomes and patient satisfaction when shared medical appointments are part of the treatment plan for obese patients. An in-depth look at why.